JSS Medical College and ICMR CCoE: A Partnership for Advancing Research and Policy Development in Health

In July 2023, the Centre for Excellence in Molecular Biology and Regenerative Medicine (CEMR) at the Department of Biochemistry, JSS Medical College, applied to become one of the Indian Council of Medical Research (ICMR) – Collaborating Centres of Excellence (ICMR-CCoE). Under the leadership of Dr. Akila Prashant, the centre was selected as one of only 25 out of 128 applicants, underscoring its commitment to cutting-edge research).

This selection highlights JSS Medical College's direct involvement in advancing national health policies and contributing to SDG initiatives in several key ways:

1. Setting Standards in Research: As an ICMR-CCoE, CEMR is dedicated to developing standardized guidelines in molecular biology and regenerative medicine. By establishing these guidelines, the center plays a vital role in ensuring quality research practices that align with SDG 3: Good Health and Well-being. This initiative supports the national health agenda, addressing critical health challenges through evidence-based practices.

---

2. Leading Multicentric Research Projects: The centre leads and participate in multicentric research projects that involve collaboration with various institutions. This engagement allows for the identification of health problems and challenges at multiple levels, facilitating the development of effective policies and strategies to address these issues. Such collaboration enhances adaptive management by modeling likely futures with and without interventions, thereby directly contributing to SDG 17: Partnerships for the Goals.

---

3. Capacity Building and Training: CEMR focuses on capacity building by training researchers and students in advanced methodologies in molecular biology and regenerative medicine. The successful completion of the ICMR Scientists’ Observership Program at JSS Medical College exemplifies this commitment. This program not only provided intensive training but also strengthened collaborative research efforts between JSS Medical College and ICMR. The participation of ICMR-nominated scientists reflects the commitment to knowledge exchange and skill enhancement, vital for advancing healthcare solutions.

---

4. Facilitating Resource Sharing: CEMR promotes resource sharing for collaborative research and education, enabling institutions to work together more effectively. This collaborative spirit enhances innovation in healthcare and scientific development, which is crucial for addressing public health challenges outlined in the SDGs.

---

5. Driving Innovation in Healthcare: Through its pioneering role in advancing medical research, CEMR is positioned to drive innovation in healthcare practices. This is essential for the continuous improvement of health systems and the implementation of policies that align with the goals of the ICMR and the broader public health framework.

---

In summary, the Centre for Excellence in Molecular Biology and Regenerative Medicine at JSS Medical College actively contributes to national government and regional non-government organizations' SDG policy development. Through its recognition as an ICMR-CCoE, the centre plays a critical role in advancing research, enhancing capacity, and promoting innovative healthcare solutions that align with the Sustainable Development Goals. This collaborative approach not only addresses immediate health challenges but also fosters long-term improvements in health systems and public health outcomes.

Joint Efforts for Safer Medications: JSS College of Pharmacy and Indian Pharmacopoeia Commission’s Centre of Excellence in Pharmacovigilance

The Department of Pharmacy Practice at JSS College of Pharmacy, Mysuru, has emerged as a Centre of Excellence in Pharmacovigilance, recognized by the Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission. This designation reflects the department's commitment to advancing public health through rigorous monitoring of medication safety and proactive engagement with national health policies.

Since its recognition as a Peripheral Center in 2004, the department has made significant strides in pharmacovigilance. In 2010, it became an Adverse Drug Reaction Monitoring Centre (AMC), and by 2011, it earned the status of a Regional Training Centre (RTC) under the PvPI. This progression highlights the department's pivotal role in implementing a comprehensive adverse drug reaction (ADR) monitoring system that has identified and reported over 30,000 individual safety case reports to relevant authorities.

In the past year alone, the department reported 1,486 ADRs, 312 Adverse Events Following Immunization (AEFIs), 3,609 Medication Incidents (MIs), and 137 Medical Device Adverse Events (MDAEs). This extensive data collection is crucial for identifying potential public health challenges and informing necessary interventions to improve medication safety.

Moreover, the department actively engages in sensitization and awareness programs targeting clinicians, practicing pharmacists, and the general public. These initiatives are essential for fostering a culture of safety and vigilance regarding medication use and potential adverse reactions. By educating stakeholders, the department contributes significantly to the overarching goal of enhancing patient safety and public health outcomes.

The recognition from PvPI as one of the top performers in India underscores the department's impact on national health initiatives. A distinguished professor from the Department of Pharmacy Practice has also been appointed as a member of the Signal Detection Committee, which assesses the database for signals of possible significance for public health, drug regulation, and scientific advancement. This involvement illustrates the department's direct contribution to the development of national health policies and its alignment with the Sustainable Development Goals (SDGs).

In summary, JSS College of Pharmacy's Department of Pharmacy Practice plays a crucial role in national government and regional non-government organizations' SDG policy development by:

• Identifying Problems and Challenges: The department’s extensive monitoring of ADRs and medication incidents provides critical data that identifies safety challenges within the healthcare system.

---

• Developing Policies and Strategies: By engaging with the PvPI and other health authorities, the department contributes to the formulation of policies that enhance pharmacovigilance practices nationwide.

---

• Modeling Likely Futures with and without Interventions: The department’s data on medication safety informs future projections and strategies for improving patient safety and public health outcomes.

---

• Monitoring and Reporting on Interventions The comprehensive reporting of ADRs, AEFIs, MIs, and MDAEs allows for effective monitoring of medication safety interventions.

---

• Enabling Adaptive Management: The department’s continuous education and awareness initiatives facilitate adaptive management of pharmacovigilance practices, ensuring they remain relevant and effective in improving health outcomes.

---

Through these efforts, the Department of Pharmacy Practice at JSS College of Pharmacy continues to lead the way in advancing pharmacovigilance, thereby contributing to safer medication practices and a healthier society.



Statistics of comprehensive patient safety initiatives by department of pharmacy practice



Certificate of Appreciation received from PvPI, IPC

Advancing Pharmacy Education and Practice: JSS College of Pharmacy's Role as a Centre for Continuous Professional Development

JSS College of Pharmacy's Commitment to Professional Development

The Department of Pharmacy Practice at JSS College of Pharmacy, Mysuru, has been officially recognized as a Centre for the training of practicing pharmacists by the Karnataka State Pharmacy Council (KSPC). This prestigious designation is part of the Continuous Professional Development (CPD) Program aimed at enhancing the skills and knowledge of pharmacists within the Mysuru district. This initiative aligns with national healthcare goals by fostering a culture of lifelong learning and continuous improvement in the pharmacy profession.

Impactful CPD Programs

Over the past year, the department has successfully organized several CPD programs focusing on essential areas of pharmacy practice, including “Antimicrobial Stewardship” and “Medication Adherence.” These programs have attracted over 75 practicing pharmacists, providing them with the latest insights and strategies to improve patient care and outcomes. By addressing contemporary challenges in pharmacy practice, the department plays a crucial role in ensuring that pharmacists are equipped to meet the evolving needs of the healthcare system.

Role in Curriculum Development

In addition to its CPD initiatives, KSPC has appointed an Associate Professor from the Department of Pharmacy Practice as an expert in the Training of Teachers (ToT) program. This role involves training educators of Diploma in Pharmacy programs on a newly implemented curriculum, ensuring that future pharmacists receive high-quality education aligned with current industry standards. This collaborative effort enhances the overall quality of pharmacy education in the region.

Commitment to Advancing the Pharmacy Profession

The recognitions received by the Department of Pharmacy Practice reflect JSS College of Pharmacy’s broader mission to contribute to the advancement of the pharmacy profession. Through its dedicated efforts in professional development and education, the department is cultivating a well-informed, skilled workforce that can effectively respond to the healthcare needs of the community.

These initiatives exemplify the active involvement of JSS College of Pharmacy in enhancing pharmacy practice and education in alignment with national healthcare policies and standards. By engaging with local pharmacy councils and focusing on critical training areas, the college contributes to improving healthcare outcomes in the region while ensuring that pharmacy professionals are equipped to tackle current and future challenges in the field.

Group photo of participants of CPD program on Anti Microbial Stewardship Program

Resource Persons during their her presentation on Medication Adherence at a CPD program

Enhancing Regulatory Affairs Education: JSS College of Pharmacy’s Collaboration with Biocon Academy through the Centre of Excellence in Regulatory Sciences

JSS College of Pharmacy’s Commitment to Regulatory Sciences

The Centre of Excellence in Regulatory Sciences (CEReS) at the Department of Pharmaceutics, JSS College of Pharmacy, Mysuru, plays a pivotal role in advancing education and training in regulatory affairs. Inaugurated by Dr. Sarah McMullen, Country Director of the United States Food and Drug Administration (US-FDA) India Office on November 30, 2022, CEReS aims to bridge the gap between subject matter experts (SMEs), regulators, and academia. This initiative addresses critical regulatory issues and propels research in regulatory sciences, which is essential for public health and safety.

Collaboration with Biocon Academy

JSS College of Pharmacy has partnered with Biocon Academy to offer the “Biocon-JSSAHER Certificate Program in Global Regulatory Affairs” (GRA). As a knowledge partner, JSS AHER is dedicated to equipping students with the necessary skills and knowledge to excel in the field of regulatory affairs. The 16-week GRA program encompasses six key subject areas relevant to global and industrial regulatory requirements, ensuring that students gain comprehensive insights into pharmaceutical regulations.

The program is designed to deliver both theoretical knowledge and practical training. Faculty members from JSS College of Pharmacy provide didactic lectures online for 16 weeks, followed by five days of hands-on training at the JSSCP campus. This practical component includes internships and collaborations with industry leaders, ensuring that graduates are well-prepared to navigate real-world regulatory challenges.

Impact on Students and the Pharmaceutical Sector

The GRA program has successfully placed graduates in reputable pharmaceutical and biopharmaceutical organizations, where they take on significant roles in ensuring compliance with regulatory standards. The curriculum was meticulously proposed by JSS AHER and reviewed and accepted by Biocon Academy, ensuring its relevance and applicability to current industry practices.

CEReS, through its collaboration with Biocon Academy, not only contributes to the professional development of pharmacy students but also enhances the capacity of the regulatory workforce. By fostering a dynamic learning environment, the program prepares graduates to address complex regulatory challenges, ultimately supporting national public health initiatives.

Contribution to Policy Development and Capacity Building

The involvement of JSS College of Pharmacy in the GRA program exemplifies its direct contribution to the development of the regulatory affairs workforce, which is critical for effective policy implementation in the pharmaceutical sector. By identifying challenges and equipping students with the knowledge to address them, JSS College of Pharmacy plays a crucial role in shaping the future of regulatory affairs in India.

In conclusion, through initiatives like CEReS and the collaboration with Biocon Academy, JSS College of Pharmacy, Mysuru, demonstrates its commitment to advancing the field of regulatory sciences. This partnership not only enhances the education of future professionals but also aligns with broader national health goals, ensuring a safer and more effective pharmaceutical landscape.

Figure 1: Dr. Sarah McMullen, Country Director, US-FDA INO and her team inaugurating the Centre of Excellence in Regulatory Sciences on 30th November 2022

Figure 2: Faculty of JSSCP Mysuru and students of GRA Batch 3

Figure 3: Hands-on-training activities at JSSCP Mysuru for GRA Batch 3

Mysore District Health Risk Assessment (MUDHRA) Cohort Study (2006 – Ongoing)

Research Focus: Health impacts of biomass fuel exposure

Lead Investigator: Dr. Mahesh PA

SDG Alignment: SDG 3 (Good Health and Well-being), SDG 7 (Affordable and Clean Energy), SDG 13 (Climate Action)

The MUDHRA Cohort Study examines the long-term health effects of biomass fuel exposure, especially on women in rural areas of southern India. With over 8,457 participants from 16 villages, the study has generated crucial evidence that influenced national health and energy policies.

• Key Findings:
  • Women exposed to biomass fuels have an increased risk of chronic bronchitis and COPD after 15 years of exposure.
  • Biomass fuel use is linked to higher all-cause mortality rates in women compared to heavy smokers.
• Policy Impact:
  • The findings from the MUDHRA study directly contributed to the Pradhan Mantri Ujjwala Yojana (PMUY), a government initiative to provide clean cooking fuels (LPG) to rural households. This policy intervention supports SDG 7 by promoting cleaner energy sources and SDG 3 by reducing respiratory diseases caused by biomass fuel exposure.
• Role in Policy Development:
  • JSS AHER’s research provided data used to model the future health benefits of switching to clean cooking fuels. The university actively reports the progress and impact of the PMUY program through the ongoing MUDHRA cohort, ensuring adaptive management and continued support for clean energy initiatives.

Air Pollution and Adolescent Lung Health (APEAL) Study (2020 – Ongoing)

Research Focus: Impact of urban air pollution on adolescent lung function

Lead Investigator: Dr. Mahesh PA

SDG Alignment: SDG 3 (Good Health and Well-being), SDG 13 (Climate Action)

The APEAL Study evaluates the effects of air pollution on the lung health of 4,143 adolescents across four major Indian cities: Mysore, Bangalore, Mumbai, and Delhi.

• Key Findings:
  • Over 50% of adolescents involved in the study show reduced lung function due to even moderate levels of air pollution.
  • Mumbai reported the most severe impact, correlating high pollution levels with significant lung function decline.
• Policy Impact:
  • The study’s results have highlighted the need for stricter air quality standards and more targeted public health interventions to protect children from the adverse effects of pollution.
  • APEAL’s findings have influenced policies that address air quality monitoring and pollution control in urban areas, aligning with SDG 13 (Climate Action) by advocating for sustainable solutions to combat urban air pollution.
• Role in Policy Development:
  • JSS AHER provides ongoing data to policymakers to forecast the long-term consequences of failing to act on urban air pollution. These projections help shape future policies aimed at reducing air pollution and its health impacts.

Burden of Obstructive Lung Disease (BOLD) Study (2009-2011, 2019-2020)

Research Focus: Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in diverse regions

Lead Investigator: Dr. Mahesh PA

SDG Alignment: SDG 3 (Good Health and Well-being)

The BOLD Study investigates COPD prevalence in three epidemiologically distinct regions of India: Mysore, Pune, and Kashmir.

• Key Findings:
  • High COPD rates in Kashmir due to significant smoking habits, compared to lower prevalence in Mysore and Pune.
  • A significant reduction in smoking rates from 50% to 15% in Kashmir highlights the impact of anti-smoking campaigns.
• Policy Impact:
  • The study’s findings have supported the implementation of smoking cessation programs and targeted COPD prevention strategies in high-risk regions like Kashmir.
  • The evidence provided by BOLD contributed to SDG 3 by promoting well-being and reducing the prevalence of respiratory diseases through policy interventions.
• Role in Policy Development:
  • JSS AHER has provided real-time data to the government on the effectiveness of smoking cessation programs, allowing for adaptive management and refinement of tobacco control strategies.

Sickle Cell Disease (SCD) Research and Policy Development

Dr. Deepa Bhat’s projects on sickle cell disease (SCD) screening and management, funded by the Indian Council of Medical Research (ICMR) and the India Alliance Wellcome Trust, focus on improving health outcomes for marginalized populations. These projects are crucial in identifying health challenges and formulating district- and state-level interventions aligned with the Sickle Cell Elimination Mission. Through collaborations with the Department of Biotechnology, Government of India, and various international partners, JSS AHER actively contributes to addressing neglected health conditions in tribal communities.

• Key Inputs to Policy Development:
  • Problem Identification and Evidence Generation: Dr. Bhat’s research identifies key health issues affecting tribal populations, particularly the prevalence and impact of sickle cell disease. By assessing stigma, economic loss, and quality of life, her work addresses SDG 3 (Good Health and Well-being) and SDG 10 (Reduced Inequalities).

  ---

  • Capacity Building and Training: The AMBARI Novartis-funded initiative, led by Dr. Bhat, developed a comprehensive training module for healthcare providers across Karnataka. These materials were instrumental in establishing effective SCD management strategies and have been adopted by the National Health Mission (NHM) in Karnataka.

  ---

  • Policy Strategy and Development: As a technical committee member of NHM and a Master Trainer, Dr. Bhat’s expertise informs the design of guidelines for SCD screening, treatment, and elimination. This process exemplifies how research at JSS AHER directly feeds into policy-making at the state and national levels, ensuring evidence-based interventions are put in place.

  ---

  • Monitoring, Reporting, and Adaptive Management: The work package on “translational synthesis” within Dr. Bhat’s projects focuses on converting research findings into actionable insights for policymakers. Continuous monitoring of these programs allows for adaptive management, ensuring policies are responsive to emerging challenges in tribal health.

  ---

  • Collaborative Networks for SDG Impact:
  • JSS AHER’s collaborations with Bodoland University, the Institute of Public Health, Novartis, and government bodies foster a multi-sectoral approach to SDG policy development. These partnerships contribute to advancing SDG 17 (Partnerships for the Goals), ensuring that JSS AHER's research is aligned with national health strategies and global goals.

Direct Involvement of JSS AHER in National and Regional SDG Policy

• Development through Cervical Cancer Research JSS Academy of Higher Education and Research (JSS AHER) is actively engaged in addressing critical public health challenges, particularly in the realm of cervical cancer, which is a significant health concern for women in India. The institution, through its dedicated research initiatives led by Dr. M.V.S.S.T. Subbarao and collaborations with various national and international partners, plays a vital role in influencing national and regional Sustainable Development Goal (SDG) policies. By identifying key challenges in cervical cancer screening and treatment, developing innovative diagnostic tools, and promoting targeted vaccination strategies, JSS AHER is contributing to the advancement of public health policy and practices aimed at reducing the burden of cervical cancer in India. This involvement not only aids in addressing immediate healthcare needs but also supports broader goals related to health equity and improved health outcomes for women across the nation.

---

• Capacity Building and Training: The AMBARI Novartis-funded initiative, led by Dr. Bhat, developed a comprehensive training module for healthcare providers across Karnataka. These materials were instrumental in establishing effective SCD management strategies and have been adopted by the National Health Mission (NHM) in Karnataka.

---

• Identifying Challenges in Cervical Cancer Screening and Vaccination JSS AHER, through the research led by Dr. M.V.S.S.T. Subbarao, has addressed the critical gaps in cervical cancer screening and vaccination in India. The institution has identified major challenges, such as limited access to affordable HPV vaccines and the need for targeting the appropriate high-risk HPV genotypes in the Indian population. The identification of HPV59 and HPV33 genotypes alongside HPV16 and HPV18 has provided essential insights for national vaccination programs, contributing to policy developments that focus on including genotype-specific vaccines.

---

• Development of Screening and Diagnostic Tools A key contribution of JSS AHER to national SDG policies is the development of innovative diagnostic tools. The institution's collaborative research with the University of Arizona aims to enhance the specificity of cervical cancer screening through the development of microRNA panel sets. Supported by SERB-CII through the Prime Minister’s Fellowship, these tools aim to improve detection accuracy, avoiding the pitfalls of false diagnoses, and informing national cervical cancer screening guidelines.

---

• Promoting Targeted HPV Vaccination to Optimize Resources Dr. Subbarao’s research highlights the importance of vaccinating younger girls (ages 9–12 years) to prevent HPV infections and minimize vaccine wastage. The institution’s research informs national strategies on how to best allocate limited vaccination resources by identifying individuals who need the vaccine through targeted screening efforts. These findings have directly contributed to policy discussions on optimizing HPV vaccine distribution, aligning with India’s goal to eliminate cervical cancer by 2030.

---

• Increasing Participation in Cervical Cancer Screening Programs JSS AHER has taken active steps to promote cervical cancer screening, particularly in rural areas, where participation remains low. In collaboration with the Public Health Research Institute of India, JSS AHER organized screening camps in rural Mysuru, supported by the DST’s PURSE scheme. These initiatives have identified women at risk and contributed valuable data to help shape national screening strategies, thereby supporting SDG 3 (Good Health and Well-being).

---

• Advancing Treatment Strategies for Advanced Cervical Cancer JSS AHER’s research extends beyond prevention to the treatment of advanced cervical cancer. In collaboration with ICMR, Dr. M.N. Suma’s study explores the therapeutic role of hydroxyprostaglandin dehydrogenase (HPGD), identifying Hydroxychloroquine (HCQ) as a potential treatment for late-stage cervical cancer. This research is critical for the development of new treatment protocols, contributing to national health policies and advancing cancer care in India.

---

• Research into Cervicovaginal Environment and Cancer Development JSS AHER is pioneering research to understand why certain women with HPV infection progress to cervical cancer while others do not. By studying the cervicovaginal environment, including metabolome, microbiome, and cytokinome profiles, the institution aims to uncover key factors in cancer development. This research, supported by SERB-CII through the Prime Minister’s Fellowship, is expected to inform future national policies on personalized medicine and cancer prevention.

---

• Collaborative Networks and Policy Impact JSS AHER’s collaborative efforts with international institutions like the University of Arizona and local organizations such as the Public Health Research Institute of India strengthen its contributions to SDG policy development. These partnerships enable the institution to extend the impact of its research, influencing both national and international cervical cancer prevention strategies and ensuring the integration of research findings into policy frameworks.

Dr. Pratibha Pereira

Introduction

JSS Academy of Higher Education and Research (JSS AHER) plays a vital role in addressing the healthcare challenges faced by the elderly population in India. Under the leadership of Dr. Pratibha Pereira, the Department of Geriatric Medicine is committed to enhancing the quality of life for older adults and improving healthcare services tailored to their needs. Through various initiatives and collaborations, JSS AHER is actively contributing to national and regional Sustainable Development Goal (SDG) policies related to health and well-being. This involvement includes direct engagement with government bodies and other organizations to identify challenges, develop effective policies, and implement innovative solutions that promote healthy aging.

Involvement in National and Regional SDG Policy Development

• Establishment of Clinical Research Excellence Dr. Pratibha Pereira played a pivotal role in bringing the Centre of Clinical Research Excellence to JSS Hospital Mysore in collaboration with the Clinical Development Services Agency (CDSA) under the Department of Biotechnology, Government of India. This state-of-the-art facility enhances clinical research capabilities, enabling the institution to contribute valuable data and insights that inform national health policies, particularly those focused on geriatric care.

---

• G20 Summit Contributions As a core group member of the Elderly Health & End of Life Care team for the G20 Summit in India in 2023, Dr. Pereira has been instrumental in shaping discussions around elderly health policies. Her involvement ensures that the unique needs of older adults are considered in international dialogues, influencing future policies and strategies at both national and global levels.

---

• Multicentric Study on COVID-19 Prevention Dr. Pereira is the principal investigator of a multicentric study assessing the safety profile of BCG revaccination for COVID-19 prevention among elderly individuals in India. This research not only addresses immediate health concerns arising from the pandemic but also contributes to the development of effective vaccination policies tailored for vulnerable populations.

---

• NABH Assessment and Training As a certified NABH assessor, Dr. Pereira has conducted evaluations of numerous hospitals and ethics committees throughout India. Her assessments support the implementation of best practices and adherence to ethical standards, directly contributing to improved healthcare quality and safety for elderly patients.

---

• Quality Council of India Participation Dr. Pereira’s role in the Quality Council of India (QCI) involves pilot assessments of healthcare institutions for QCI rankings. This work facilitates the development of a specific ranking framework for healthcare institutions, ensuring that quality metrics are aligned with national health objectives and standards.

---

• Empowerment through BIRAC Projects Through her collaboration with the Department of Biotechnology for the BIRAC project, Dr. Pereira empowers medical institutions to conduct immunogenicity studies for COVID-19 vaccines. This initiative enhances research capabilities while contributing to national vaccination strategies and policy formulation.

---

• Training in Good Clinical Practices As a master trainer for Good Clinical Practice training programs, Dr. Pereira plays a crucial role in educating clinical researchers across India. By promoting adherence to ethical and scientific standards in clinical trials, she supports the development of robust research that informs health policy and practices for elderly care.

Establishing Continuum of Care for Tuberculosis Patients: A Collaborative Initiative with Karnataka Health Promotion Trust

Focus: Implementation research aimed at enhancing TB patient care in Karnataka.

• Establishment of Collaborative Partnerships Dr. Praveen Kulkarni has been instrumental in establishing a Memorandum of Understanding (MOU) with the Karnataka Health Promotion Trust (KHPT) focused on implementing research aimed at establishing a continuum of care for tuberculosis patients in the region. This partnership reflects JSS AHER’s commitment to working alongside governmental and non-governmental organizations to tackle critical health challenges.

---

• Implementation Research for Tuberculosis The collaborative research project initiated under this MOU has provided valuable insights into the TB care continuum in Karnataka. By identifying gaps in patient care and barriers to effective treatment, the research addresses pressing issues that impact public health. The findings from this project have the potential to inform policymakers, guiding them in developing targeted strategies to enhance TB control efforts.

---

• Influencing National Policy Changes The outcomes of the research conducted in partnership with KHPT have played a key role in bringing about policy changes in the Revised National Tuberculosis Control Program (RNTCP) of the Government of India. By demonstrating effective models of care and highlighting areas for improvement, JSS AHER contributes to national efforts aimed at reducing the burden of TB, a critical health issue that aligns with the SDG target of ending the global tuberculosis epidemic by 2030.

---

• Identifying Challenges and Developing Strategies Through this initiative, JSS AHER actively identifies problems and challenges within the TB healthcare framework. The research findings serve as a basis for developing evidence-based policies and strategies that address the unique needs of TB patients in Karnataka, ensuring that interventions are tailored to the local context.

---

• Monitoring and Reporting on Interventions The research initiative includes a component for monitoring the effectiveness of the continuum of care model for tuberculosis patients. By systematically evaluating the impact of implemented strategies, JSS AHER and its partners can report on the progress made, enabling adaptive management and continuous improvement of TB care services.

---

• Enabling Adaptive Management By collaborating with government bodies and health organizations, JSS AHER fosters an environment of adaptive management. The insights gained from the research inform ongoing efforts to refine and enhance TB control policies, ensuring they remain responsive to emerging challenges and changes in the healthcare landscape.

Enhancing Healthcare Policy through Research: Dr. Praveen Kulkarni's Contributions to Diabetes and Hypertension Care in India

Introduction

JSS Academy of Higher Education and Research (JSS AHER) actively participates in shaping national health policies through impactful research initiatives. Dr. Praveen Kulkarni's collaboration with the ICMR-National Centre for Disease Informatics and Research (NCDIR), Bangalore, and the World Health Organization (WHO) on the "Rapid Assessment of Continuum of Care for Diabetes and Hypertension in India" exemplifies this commitment. This project has played a pivotal role in facilitating significant policy changes within the National Program for Prevention and Control of Non-Communicable Diseases.

Involvement in National Policy Development

• Modelling Likely Futures: By analyzing data from the continuum of care assessment, Dr. Kulkarni's work has enabled stakeholders to model potential futures with and without specific interventions. This foresight assists policymakers in understanding the implications of different strategies on public health.

---

• Monitoring and Reporting on Interventions: The collaboration has also set the stage for systematic monitoring and reporting mechanisms to evaluate the effectiveness of implemented policies and interventions in real-world settings. This feedback loop is crucial for continuous improvement in healthcare delivery.

---

• Enabling Adaptive Management: Through ongoing collaboration and data sharing, Dr. Kulkarni’s efforts have contributed to creating a flexible approach to managing public health initiatives, allowing for adjustments based on emerging evidence and changing health needs.

---

• Conclusion Dr. Praveen Kulkarni’s research efforts exemplify JSS AHER's dedication to influencing national health policy through evidence-based initiatives. By addressing the complexities of diabetes and hypertension care, these projects not only contribute to immediate health improvements but also align with the broader goals of sustainable development in healthcare.

Advancing Adolescent Health through Innovative Interventions: Family Intention Assessment

Introduction

At JSS Academy of Higher Education and Research (JSS AHER), we are committed to driving meaningful change in health policy through innovative research initiatives. Dr. Praveen Kulkarni’s involvement as a co-investigator in a game-based intervention project sponsored by the Bill and Melinda Gates Foundation, in collaboration with Quinnipiac University, USA, exemplifies this dedication. This project aims to assess family intentions among adolescents and plays a critical role in shaping health policies related to adolescent well-being.

Involvement in National Policy Development

1. Identifying Problems and Challenges: The game-based intervention seeks to identify key challenges faced by adolescents in discussing health-related intentions within their families. By understanding these dynamics, the research addresses barriers to open communication and education regarding health issues, which is vital for promoting healthy behaviors among young people.

---

2. Developing Policies and Strategies: Insights gained from this research can inform policymakers in crafting strategies that encourage family engagement in health discussions, particularly concerning adolescent health and well-being. By integrating these findings into existing public health frameworks, stakeholders can promote more effective interventions that support adolescents in navigating their health journeys.

---

3. Modelling Likely Futures: The innovative nature of the game-based intervention allows for the exploration of various scenarios regarding family interactions and health intentions. By modeling these scenarios, the project can predict potential outcomes of different intervention strategies, providing valuable information to policymakers on the effectiveness of proposed approaches.

---

4. Monitoring and Reporting on Interventions: Through systematic data collection and analysis during the intervention, the project establishes a framework for monitoring the impact of family engagement strategies on adolescent health intentions. This evidence-based approach allows for ongoing assessment and reporting, ensuring that interventions remain effective and relevant.

---

5. Enabling Adaptive Management: The project’s collaborative nature, involving international partners and diverse stakeholders, fosters an adaptive management approach. As new insights are gained from the intervention, the strategies can be modified in real-time to better meet the needs of adolescents and their families, ultimately enhancing the effectiveness of public health initiatives.

---

6. Conclusion Dr. Praveen Kulkarni’s participation in this innovative project demonstrates JSS AHER’s commitment to advancing health policies through collaborative, evidence-based research. By focusing on family intentions and adolescent health, this initiative aligns with the broader goals of sustainable development and reinforces the importance of community engagement in public health strategies.

Community-Based Research on Non-Communicable Diseases Among Jenu Kuruba Tribals: Informing National Health Policies

Introduction

At JSS Academy of Higher Education and Research (JSS AHER), we recognize the critical importance of research in shaping effective health policies. Dr. H. Basavana Gowdappa, a Professor of General Medicine and Principal at JSS Medical College, has played a pivotal role in advancing our understanding of non-communicable diseases (NCDs) through extensive community-based research. His leadership in a large-scale study among the Jenu Kuruba tribal population has significantly contributed to national health initiatives aimed at controlling NCDs.

Involvement in National Policy Development

1. Identifying Problems and Challenges: Dr. Gowdappa led a comprehensive community-based study from 2009 to 2012, which focused on the prevalence of hypertension and diabetes among the Jenu Kuruba tribals, involving a sample size of 7,500 individuals. This research identified significant health challenges within this tribal community, highlighting the urgency of addressing NCDs among marginalized populations.

---

2. Developing Policies and Strategies: The findings from this study served as a vital resource for the design and implementation of the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS), which has now evolved into the National Program for Prevention and Control of Non-Communicable Diseases. By providing evidence on the prevalence and risk factors associated with NCDs in tribal communities, the research has directly informed policy strategies aimed at mitigating these health issues.

---

3. Modelling Likely Futures: Through the data collected, the study allowed for the modelling of potential health outcomes associated with various intervention strategies targeting NCDs. By analyzing different scenarios based on the prevalence of these diseases, policymakers could better understand the long-term implications of current health policies and plan accordingly.

---

4. Monitoring and Reporting on Interventions: The comprehensive nature of the research provides a framework for ongoing monitoring of NCDs in tribal populations. By establishing baseline data, the study enables health authorities to assess the impact of implemented interventions over time and refine strategies as necessary.

---

5. Enabling Adaptive Management: The insights gained from Dr. Gowdappa’s research support an adaptive management approach in health policy. As new data and trends emerge, the flexibility inherent in this research allows for the modification of interventions to better address the evolving needs of the community, thereby enhancing the overall effectiveness of public health initiatives.

---

6. Conclusion Dr. H. Basavana Gowdappa’s extensive research on non-communicable diseases among the Jenu Kuruba tribals illustrates JSS AHER's commitment to impacting national health policies. By identifying critical health challenges and informing strategic responses, this initiative not only addresses immediate health needs but also contributes to the broader goals of sustainable development in India. Through such research, JSS AHER continues to play an active role in shaping health policies that enhance the well-being of underserved communities.

Improving Clinical Practices in ENT: A National Collaborative Project

Introduction

At JSS Academy of Higher Education and Research (JSS AHER), we are committed to enhancing healthcare through education, research, and policy development. Dr. Bharathi MB, a Professor and Head of the Department of ENT at JSS Medical College, has made significant contributions to the field of otorhinolaryngology (ENT) in India. As the national president of the National Association of Otorhinolaryngologists, Dr. Bharathi has been instrumental in shaping educational standards and clinical practices across the country.

Involvement in National Policy Development

1. Identifying Problems and Challenges: Dr. Bharathi has been actively involved in recognizing the gaps and challenges within the education and practice of ENT in India. Her leadership role has enabled her to gather insights from practitioners and educators, highlighting areas in need of improvement in the curriculum and clinical care practices.

---

2. Developing Policies and Strategies: Through her position in the National Association of Otorhinolaryngologists, Dr. Bharathi has collaborated with the National Medical Commission and other professional bodies to advocate for necessary changes in the undergraduate and postgraduate ENT curriculum. This collaboration aims to ensure that medical education meets the evolving needs of healthcare delivery and patient care in the field of otorhinolaryngology.

---

3. Modelling Likely Futures: By assessing the current landscape of ENT education and practice, Dr. Bharathi has contributed to modelling potential futures with and without specific educational interventions. This foresight helps stakeholders understand the long-term impacts of curriculum changes and the importance of aligning educational outcomes with the demands of modern medical practice.

---

4. Monitoring and Reporting on Interventions: Dr. Bharathi's involvement in the National Association of Otorhinolaryngologists includes monitoring the implementation of revised curricula and clinical guidelines. This process not only ensures adherence to established standards but also provides a mechanism for evaluating the effectiveness of these changes in improving education and clinical outcomes in ENT.

---

5. Enabling Adaptive Management: The dynamic nature of healthcare requires continuous adaptation and improvement. Dr. Bharathi's leadership facilitates adaptive management by allowing for the ongoing assessment of educational practices and clinical guidelines. By incorporating feedback and new evidence into the curriculum, she helps ensure that the training of future ENT specialists remains relevant and effective.

---

6. Conclusion Dr. Bharathi MB's significant contributions to enhancing education and clinical practices in otorhinolaryngology reflect JSS AHER's commitment to influencing national health policy. By collaborating with national organizations and advocating for improvements in medical education, Dr. Bharathi is not only addressing immediate challenges but also contributing to the long-term sustainability and effectiveness of healthcare in India. Through her efforts, JSS AHER continues to play an essential role in shaping the future of ENT education and practice, ultimately benefiting patients and communities across the nation.

Transforming Health Care: Dr. Anil Bilimale's Involvement in National Health Program Modifications

Introduction

Dr. Anil S. Bilimale, Chief Coordinator of the School of Public Health at JSS Medical College, has been at the forefront of public health research and policy development in India. His work has significantly impacted the national health landscape, particularly in the areas of disease prevention, health system evaluation, and vaccine research. By collaborating with various national and international organizations, Dr. Bilimale's projects have informed critical health policies and practices, aligning with the Sustainable Development Goals (SDGs).

1. Evaluation of Health and Wellness Centres in KarnatakaAs the Principal Investigator for evaluating health and wellness centres across various districts in Karnataka, Dr. Bilimale led a comprehensive assessment of these facilities. Funded by the World Health Organization (WHO) and the Government of India, this project yielded valuable insights that facilitated modifications in the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke. This initiative not only addressed existing health challenges but also contributed to the strategic development of healthcare policies aimed at improving public health outcomes in the region.

---

2. COVID-19 Vaccine Safety and Efficacy Study Dr. Bilimale played a pivotal role in comparing the safety and efficacy of Covishield and Covaxin vaccines during the COVID-19 pandemic. Sponsored by WHO and the Indian Council of Medical Research (ICMR), the findings of this study provided essential data supporting the safe use of these vaccines, influencing public health strategies and vaccination campaigns across the country. This research underscores the university's commitment to advancing health policies based on scientific evidence and effective intervention strategies.

---

3. Dengue Vaccine Trial Involved in a groundbreaking dengue vaccine trial, Dr. Bilimale's research has significant implications for introducing dengue vaccines into India’s national immunization program. This milestone study addresses a critical public health concern by exploring strategies to prevent and control dengue outbreaks, thereby contributing to national health policy development aimed at enhancing vaccine accessibility and efficacy.

---

4. Collaborations and PartnershipsDr. Bilimale has established crucial collaborations and MOUs with various national and international organizations, including the Grassroots Research and Advocacy Movement (GRAAM), University of Arizona, Public Health Research Institute of India, Institute of Public Health (Bangalore), Boston University, and Piramal Swasthya. These partnerships enhance the university's capacity to influence health policies by integrating research findings into practical applications, thereby enabling adaptive management in public health interventions.

---

5. Conclusion Dr. Anil S. Bilimale's extensive contributions to public health research and policy development reflect JSS Academy of Higher Education and Research's commitment to addressing national health challenges. Through rigorous evaluation, collaboration, and innovative research, the university plays a vital role in shaping health policies that align with the Sustainable Development Goals, fostering a healthier future for communities in India.

Enhancing Vaccine Safety and Public Health Policy: Contributions of Dr. M D Ravi

Initiatives

Dr. M D Ravi, Chief of the Centre of Clinical Research Excellence at JSS Hospital Mysore, has significantly contributed to national health policy development and the Sustainable Development Goals (SDGs) through his extensive work in vaccine trials and safety monitoring. His involvement in the following initiatives illustrates the university's direct engagement with national and regional organizations in shaping public health policies:

1. Vaccine Trials and ImplementationDr. Ravi played a pivotal role in conducting vaccine trials for dTaP (diphtheria, tetanus, and pertussis) and Tdap (tetanus, diphtheria, and pertussis) among children. The outcomes of these trials were instrumental in the successful integration of Tdap vaccination into India's Universal Immunization Program. This directly addresses public health challenges by enhancing childhood immunization rates and preventing vaccine-preventable diseases, contributing to SDG 3: Good Health and Well-being.

---

2. Establishment of WHO-Recognized Vaccine Safety Site:Under Dr. Ravi's leadership, JSS Hospital Mysore established a WHO-recognized site dedicated to vaccine safety monitoring. This initiative not only supports the safe administration of vaccines but also fosters trust in immunization programs, aligning with global health standards. By ensuring vaccine safety, this initiative plays a crucial role in promoting public health and responding to emerging health threats.

---

3. Participation in National and International Vaccine Safety Monitoring Teams: Dr. Ravi has been an active member of various national and international teams focused on vaccine safety monitoring through the Drug Controller General of India (DCGI), the Central Drugs Standard Control Organization (CDSCO), and other organizations. His contributions help identify problems and challenges in vaccine safety and efficacy, inform policy strategies, and model likely outcomes with and without interventions. This involvement ensures that vaccines are not only effective but also safe for public use, reinforcing the importance of adaptive management in health policies.

In summary, Dr. M D Ravi’s work exemplifies how JSS Academy of Higher Education and Research (JSS AHER) is directly involved in national and regional health policy development. Through vaccine research, safety monitoring, and active participation in health initiatives, the institution plays a crucial role in addressing public health challenges, shaping health policies, and promoting the achievement of the SDGs in India.